Skip to Content
Morningstar AustraliaMorningstar Australia
Market Centre
Market Report
Market Calendar
Discover Investments
Read the latest investing news and insights
Industry Insights
Investing content
Learn to invest in...
How to invest
Our research
Our Solutions
Featured Products and Services
The Company
Insights / Topics / MAYNE
TOPIC

MAYNE News & Analysis

Positive outlook despite Mayne's $134m full-year loss
Stocks
Positive outlook despite Mayne's $134m full-year loss
The specialty drug-maker exceeded analysts' expectations on an adjusted basis, despite posting a full-year loss of $133.98 million.
Emma Rapaport | 24 August 2018